Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion in Hip Fracture Patients

NCT03063892 is registered in ClinicalTrials.gov with Gregory M Georgiadis MD as lead sponsor.

NCT NCT03063892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03063892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion in Hip Fracture Patients
Lead sponsor
Gregory M Georgiadis MD
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 30, 2017
Completion date
September 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip fractures